Drug intelligence / Profile preview

camphor monobromide

Development stage
Unknown
Modality
Small Molecules
Administration
Topical[1]
01

Overview

Camphor monobromide is a synthetic derivative of camphor, chemically known as (1R,3S,4S)-3-bromo-1,7,7-trimethylbicyclo[2.2.1]heptan‑2‑one with the formula C₁₀H₁₅BrO and a molecular weight of approximately 231.13 g/mol[1][2][5]. It is classified as a small molecule and has been used experimentally in pharmaceutical preparations. Camphor derivatives are generally known for their topical analgesic and counterirritant properties; however, specific pharmacological actions or approved indications for camphor monobromide are not well documented in current medical literature[1]. It has appeared as an ingredient in combination topical products (e.g., with levomenthol and methyl salicylate) intended for external use such as oils or ointments[1]. The mechanism of action is presumed to be similar to that of other camphoric compounds—likely acting on cutaneous sensory nerves to produce local analgesia via counterirritation—but no direct mechanistic studies have been published.

Other names
3-bromo-d-camphor3-bromocamphorcamphor bromidecamphor, monobromated(+)-camphor bromideendo-3-bromo-D-camphorendo3-bromo-D-camphorendo 3-bromo-D-camphord-campho

Beyond the preview

Go deeper on camphor monobromide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on camphor monobromide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call